St. Luke's Cancer Institute
100 E Idaho
Boise, ID 83712
Direct phone: (208) 381-1679
Total transplants by cell source
- Marrow: 0
- PBSC: 17
- Cord Blood: 0
- Autologous (PBSC or Marrow): 56
About the center
The St. Luke's Cancer Institute – Center for Blood Cancer Therapy offers comprehensive care and cellular therapy for patients with leukemia, lymphoma, multiple myeloma, myelodysplastic disorders, and other blood cancers. We're proud to be Idaho's only blood and marrow transplant program, offering autologous and allogeneic bone marrow/stem cell transplants and CART therapies at St. Luke’s Boise. Our dedicated team focuses on your quality of life while providing novel therapies, access to clinical trials, and supportive care, close to home.
This center has been performing allogeneic transplants since 2018 and has been an NMDP/Be The Match transplant center since May 2020.
Adult - Zachary Benson, William Kreisle, Travis Williams
Cord blood transplants performed on
Other programs and services
Our program offers full support from an interdisciplinary team specialized in the care of patient under going transplant. This team includes providers, social workers, patient financial advocates, pharmacists, and nurse navigators to help guide patients through the transplant process. Local discounted housing may be available in coordination with our social work team.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2018, 2019, 2020, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 29 patients.
The actual 1-year survival of these patients is 86.2%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 57.9% and 88.8%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2020 to December 31st, 2021 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2020 to December 31st, 2021 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
Arnela Kajdic Tarantino
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)